Date: Monday, October 26, 2020
<Back to Mini Symposia Main Page
Brad Edwards, Camilla Hoyos, and Neomi Shah
Past, Present and Incoming SRN Program Committee Chairs
Moderated By: Danny Eckert, PhD and Azadeh Yadollahi, PhD
-
A Randomized, Placebo-Controlled, Double-Blind Crossover Trial Assessing the Combination of Noradrenergic/Serotonergic Reuptake Inhibitor and an Antimuscarinic Agent for the Treatment of Obstructive Sleep Apnea – Luke Thomson, BPsych(hons), GradDipSlSci (1:43)
-
Ventilatory Drive-Dependent Obstruction as the Predominant Phenotype of Obstructive Sleep Apnea – Laura Gell, PhD (18:21)
-
The Role of Fluid Accumulation in Acute Weight Gain During CPAP Treatment in Patients with Obstructive Sleep Apnea – Sara Silva, PT, PhD (35:25)
-
The Combination of Atomoxetine and Fesoterodine Improves Obstructive Sleep Apnea Severity in Patients with Low Upper Airway Collapsibility– Luigi Taranto Montemurro, MD (50:40)
-
Effect of Obstructive Sleep Apnea on the Aging Process: Role of Age and Sex– Lucia Pinilla, MSc (1:06:40)
-
Effect of Obstructive Sleep Apnea in Different Phenotypes of Patients with Acute Coronary Syndrome – Andrea Zapater, MSc (1:15:40)